Poonam Kalhotra

Instituto Politécnico Nacional Mexico

She completed her PhD in biotechnology with honors in 2020, where she discovered new mechanisms of action for chemicals and, in addition, repurposed FDA approved drugs for chronic diseases. She had contributed to the development of combination therapies, to reduce diabetic complications and developed new technologies to deliver insulin and insulin receptor modulators. In specific, she had developed nanomedicines for patients suffering from chronic diseases. She is currently working in cell stress biology research group and her research focuses on identifying mechanisms that promote the development of aggressive metastatic cancer.

Poonam Kalhotra

1chapters authored